Newswise COVID Experts

Filters close
24-Mar-2024 8:00 PM EDT
Rutgers Racing to Develop Paxlovid Replacement
Rutgers University-New Brunswick

SARS-CoV-2 will eventually become resistant to the only effective oral treatment. The world needs another.

Newswise: Pandemic Education Disruptions Likely Had Little Impact on Anxiety Levels of Autistic Teenagers
Released: 27-Mar-2024 9:05 AM EDT
Pandemic Education Disruptions Likely Had Little Impact on Anxiety Levels of Autistic Teenagers
Southern Methodist University

Study finds autistic teens' anxiety levels remained consistent amid COVID-19 disruptions to education, whether in-person, remote or homeschooled.

   
Newswise: Pandemic course improved COVID-19 knowledge, study finds
Released: 26-Mar-2024 3:05 PM EDT
Pandemic course improved COVID-19 knowledge, study finds
Washington University in St. Louis

Early in the COVID-19 pandemic, more than 1,300 students enrolled in a three-week summer immersion course, “The Pandemic: Science and Society,” at Washington University in St. Louis.

   
Released: 26-Mar-2024 3:05 PM EDT
Flu-Vaccine Education in the Emergency Department Helps People get their Shot
Thomas Jefferson University

Patient education about flu shot during a non-life threatening emergency department visit increases vaccination rates, especially in patients without regular primary care.

Newswise: Johns Hopkins Children’s Center Study Shows Negative Impact of COVID-19 Pandemic on Youth Minority Mental Health
Released: 26-Mar-2024 10:05 AM EDT
Johns Hopkins Children’s Center Study Shows Negative Impact of COVID-19 Pandemic on Youth Minority Mental Health
Johns Hopkins Medicine

Recent historical, political and public health events, most notably the COVID-19 pandemic, have collectively contributed to increased stress and mental health challenges among many groups of people — including adolescents in racial and ethnic minorities.

Not for public release

Embargo will expire: 25-Mar-2024 5:00 PM EDT Released to reporters: 19-Mar-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Research offers hope for preventing post-COVID ‘brain fog’ by targeting brain’s blood vessels
Released: 21-Mar-2024 8:55 AM EDT
Research offers hope for preventing post-COVID ‘brain fog’ by targeting brain’s blood vessels
University of Illinois Chicago

In a study of mice, researchers identified a mechanism that causes post-infection neurological problems

18-Mar-2024 2:05 PM EDT
Is the Burden of Neurologic Disease Higher After Influenza or COVID-19?
American Academy of Neurology (AAN)

People who have an influenza infection are more likely to need medical care for neurologic disorders within the next year than people who have a COVID-19 infection, according to a study published in the March 20, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released: 19-Mar-2024 3:05 PM EDT
Targeting multiple COVID variants through the twist in the spike protein
University of Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

Released: 19-Mar-2024 1:40 PM EDT
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections and Vaccines
University of Maryland School of Medicine

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.



close
2.54753